Related Experiment Video
Updated: Feb 26, 2026
Systematic Hearing Performance Evaluation Process for Adolescents with Cochlear Implantation at Early Ages
Published on: March 24, 2023
Cochlear implantation in children under 12 months of age
1UC Davis Medical Center, University of California, California, USA.
Insights
Early cochlear implantation for infants under 12 months with congenital hearing loss is safe and effective. Research suggests earlier implantation improves speech and hearing outcomes, potentially revising current FDA criteria.
Area of Science:
- Pediatric Otolaryngology
- Auditory Neuroscience
- Speech-Language Pathology
Background:
- Congenital hearing loss is increasingly identified early, necessitating timely intervention.
- Current US Food and Drug Administration (FDA) guidelines recommend cochlear implantation for children aged 12 months or older.
- Evolving research questions the 12-month age threshold for cochlear implantation.
Purpose of the Study:
- To review current literature on the safety and efficacy of cochlear implantation in infants under 12 months.
- To evaluate speech, language, and audiologic outcomes in early-implanted infants.
- To discuss the limitations and potential benefits of revising FDA criteria for pediatric cochlear implantation.
Main Methods:
- Systematic review of recent publications on pediatric cochlear implantation.
- Analysis of studies focusing on infants younger than 12 months.
- Evaluation of safety, surgical efficacy, speech/language acquisition, and audiologic results.
Main Results:
- Cochlear implantation in infants under 12 months is demonstrated as safe and effective.
- Earlier implantation is associated with enhanced speech and language acquisition.
- Infants implanted earlier can achieve normal auditory skills within 3 months post-activation.
Conclusions:
- Emerging evidence supports positive outcomes for cochlear implantation in infants under 12 months.
- Further research into earlier implantation may lead to revised FDA criteria.
- Earlier intervention can accelerate the achievement of speech and hearing potential in infants.
Purpose Of Review:
Children with congenital hearing loss are being identified earlier, leading to earlier intervention. Current US Food and Drug Administration (FDA) criteria states a child must be 12 months or older for cochlear implantation. The purpose of this article is to review recent publications regarding the benefits of implanting infants under 12 months of age. Topics include: safety and efficacy of surgery, speech and language acquisition outcomes, audiologic components, and limitations.
Recent Findings:
Since the early 1990s, the candidacy criteria evolved drastically. However, the FDA criteria for cochlear implantation in children has remained at 12 months of age or older since 2000. Recent research indicates implanting below 12 months of age a safe and effective procedure. Speech and language outcomes showed better speech and language advantages. In addition, infants implanted earlier showed normal auditory skills as early as 3 months post cochlear implant activation. This article will also address recent findings on the limitations of earlier implantation.
Summary:
Recent research demonstrates positive outcomes in children implanted under 12 months of age. Developing research on earlier implantation could lead to a change in the current FDA criteria allowing infants to reach their speech and hearing potential faster.
